During the past decade, Washington Gastroenterology conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 7 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 7 clinical trials were completed. i.e. 43.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Washington Gastroenterology" #1 sponsor was "Phathom Pharmaceuticals, Inc." with 3 trials, followed by "Arena Pharmaceuticals" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Washington Gastroenterology" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Washington Gastroenterology" are "Ulcerative Colitis" (8 trials), "Crohn's Disease" (4 trials), "Colorectal Cancer" (2 trials), "Adenoma" (1 trials) and "Adenoma Colon" (1 trials). Many other conditions were trialed in "Washington Gastroenterology" in a lesser frequency.

Most popular intervention types in "Washington Gastroenterology" are "Drug" (16 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Etrasimod" (4 trials), "Vonoprazan" (3 trials), "Golimumab" (2 trials) and "Guselkumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Washington Gastroenterology" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Washington Gastroenterology". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Washington Gastroenterology, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Washington Gastroenterology, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".